SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,568,000 | +19.0% | 151,525 | -0.3% | 0.02% | +21.4% |
| Q2 2018 | $2,158,000 | +15.4% | 151,925 | +54.3% | 0.01% | +180.0% |
| Q1 2018 | $1,870,000 | -11.4% | 98,483 | -23.5% | 0.01% | 0.0% |
| Q4 2017 | $2,110,000 | -6.5% | 128,715 | -38.5% | 0.01% | 0.0% |
| Q3 2014 | $2,257,000 | -15.6% | 209,263 | +19.4% | 0.01% | -28.6% |
| Q2 2014 | $2,675,000 | -18.9% | 175,204 | -4.0% | 0.01% | -22.2% |
| Q1 2014 | $3,300,000 | +19.7% | 182,540 | -8.1% | 0.01% | +12.5% |
| Q4 2013 | $2,758,000 | – | 198,534 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 968,505 | $12,135,000 | 1.23% |
| Golden State Equity Partners | 126,608 | $1,586,000 | 0.90% |
| McGuire Investment Group, LLC | 272,801 | $3,418,000 | 0.72% |
| Lombard Odier Asset Management (Switzerland) SA | 848,429 | $10,631,000 | 0.70% |
| Rhenman & Partners Asset Management AB | 765,000 | $9,585,000 | 0.67% |
| EMC Capital Management | 72,061 | $903,000 | 0.64% |
| WASATCH ADVISORS LP | 10,328,423 | $129,415,000 | 0.58% |
| Ceeto Capital Group, LLC | 74,000 | $927,000 | 0.45% |
| Fort Sheridan Advisors LLC | 75,945 | $952,000 | 0.38% |
| Vanguard Capital Wealth Advisors | 34,580 | $388,679,000 | 0.33% |